Active — Not RecruitingNot Applicable

Shaving Satisfaction in Males With Skin Irritation From Shaving

United States40 participantsStarted 2018-10-29

Plain-language summary

The purpose of this research study is to evaluate the improvement in overall shave satisfaction, the appearance of skin irritation from shaving, and the razor related inflammation of the hair follicles when using a new razor technology in a regular shaving regimen as well as a new razor technology in a shaving regimen that includes a pre-shave gel, cleansing brush and shaving gel.

Who can participate

Age range20 Years – 60 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Males with at least a two year history of the symptoms of skin irritation from shaving.
✓. Must be age 20-60 years of age (inclusive).
✓. Must wet shave using just a prep and blade razor at least 3 or more times per week, and be willing to shave at least 5 times per week during the study
✓. Must have Mild to moderate symptoms of skin irritation from shaving based on IGA rating scales. There must be the presence of some razor bumps but there are no lesion count inclusion requirements.

Exclusion criteria

✕. Changes in the use of systemic (oral antibiotics) within the last 4 weeks. Stable use of oral antibiotics for any condition are allowed
✕. Changes in the use of topical prescriptions
✕. Individuals who do not wet shave with a bladed razor, or who use electric shavers.
✕. Individuals who have removed a beard within last two months.

What they're measuring

Change in Shaving Satisfaction and Appearance score

Timeframe: Baseline, Week 4, Week 8, Week 12

Change in Investigator Global Severity Assessment (IGA) score

Timeframe: Baseline, Week 4, Week 8, Week 12

Trial details

NCT IDNCT03569956

SponsorWake Forest University Health Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-04-30

View on ClinicalTrials.gov More Pseudofolliculitis Barbae trials